ARCHIVES

FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators

This article is from The Cancer Letter archive.

Vol. 40 No. 30 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Secret Budget Sessions Ended; HEW Out To Lim. Future NCI Funds

April 2, 1976

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

November 16, 2001

Congress Nearing Final Action On Appropriations, But Potential GRH Cuts Leaves Outlook Unclear

September 12, 1986

Abraxane and Gemcitabine Improves Overall Survival

November 30, 2012

UPCI Recruits Shin To Lead Head & Neck Cancer Program.

April 27, 2001

ASCO Annual Meeting: New Regimens Promising For Metastatic Colon Cancer

July 28, 2006